Login / Signup

Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.

Matteo MegnaG FabbrociniE CamelaEleonora Cinelli
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • clinical trial
  • patient reported outcomes
  • community dwelling
  • atopic dermatitis